Deteriorating heath status in bronchiectasis : longitudinal data from the EMBARC registry

S. Aliberti (Milan, Italy), R. Manendez (Valencia, Spain), F. Blasi (Milan, Italy), F. Ringshausen (Hannover, Germany), A. Desoyza (Newcastle, United Kingdom), M. Vendrell (Girona, Spain), P. Goeminne (Nikolaas, Belgium), E. Polverino (Barcelona, Spain), W. Boersma (Alkmaar, Netherlands), P. Burgel (CambridgeParis, France), K. Dimakou (Athens, Greece), C. Haworth (Cambridge, United Kingdom), A. Shoemark (Dundee, United Kingdom), M. Crichton (Dundee, United Kingdom), A. Hill (Edinburgh, United Kingdom), M. Shteinberg (Haifa, Israel), M. Loebinger (London, United Kingdom), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), S. Elborn (Belfast, United Kingdom), J. Chalmers (Dundee, United Kingdom)

Source: Virtual Congress 2021 – Respiratory infections and bronchiectasis outcomes
Session: Respiratory infections and bronchiectasis outcomes
Session type: Oral Presentation
Number: 2853

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Aliberti (Milan, Italy), R. Manendez (Valencia, Spain), F. Blasi (Milan, Italy), F. Ringshausen (Hannover, Germany), A. Desoyza (Newcastle, United Kingdom), M. Vendrell (Girona, Spain), P. Goeminne (Nikolaas, Belgium), E. Polverino (Barcelona, Spain), W. Boersma (Alkmaar, Netherlands), P. Burgel (CambridgeParis, France), K. Dimakou (Athens, Greece), C. Haworth (Cambridge, United Kingdom), A. Shoemark (Dundee, United Kingdom), M. Crichton (Dundee, United Kingdom), A. Hill (Edinburgh, United Kingdom), M. Shteinberg (Haifa, Israel), M. Loebinger (London, United Kingdom), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), S. Elborn (Belfast, United Kingdom), J. Chalmers (Dundee, United Kingdom). Deteriorating heath status in bronchiectasis : longitudinal data from the EMBARC registry. 2853

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Epidemiology and health outcomes of sarcoidosis in a universal healthcare population: a cohort study
Source: Eur Respir J, 54 (4) 1900444; 10.1183/13993003.00444-2019
Year: 2019



Poor asthma control is associated with low socio-economic status: Results from a nationwide cross sectional study of Danish patients with asthma
Source: International Congress 2015 – Work, environment and the epidemiology of asthma
Year: 2015

Asthma health services utilisation before, during and after pregnancy: a population-based cohort study
Source: Eur Respir J, 51 (4) 1800209; 10.1183/13993003.00209-2018
Year: 2018



Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET
Source: ERJ Open Res, 7 (3) 00242-2021; 10.1183/23120541.00242-2021
Year: 2021



The effect of sex and age on the comorbidity burden of OSA: an observational analysis from a large nationwide US health claims database
Source: Eur Respir J 2016; 47: 1162-1169
Year: 2016



The heterogeneity of bronchiectasis patient characteristics, management and outcomes across Europe: Data from the EMBARC registry
Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Year: 2018

Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015

Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study
Source: Eur Respir J, 58 (3) 2002288; 10.1183/13993003.02288-2020
Year: 2021



Asthma management and utilization of healthcare services in children: the results of a population-based survey
Source: Eur Respir J 2001; 18: Suppl. 33, 146s
Year: 2001

Associations between lung function and dyspnoea, self-rated health, and mortality: the Nord-Trondelag health study
Source: Annual Congress 2008 - Outcome and trends in obstructive lung disease (OLD) and cardiovascular relation to OLD
Year: 2008



Demographics of patients with COPD in relation to pulmonary rehabilitation using the health improvement network (THIN)
Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases
Year: 2016


The economic burden of COPD in a Swedish cohort: The ARCTIC study
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016

Educational and health outcomes of children treated for asthma: Scotland-wide record linkage study of 683?716 children
Source: Eur Respir J, 54 (3) 1802309; 10.1183/13993003.02309-2018
Year: 2019



Identifying predictors of healthcare utilization and costs in COPD patients over 18 months: first longitudinal results of the COSYCONET cohort
Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs
Year: 2018

Demographics, clinical characteristics, health resource utilization and cost of patients with CTEPH: Retrospective results from six European countries
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Year: 2012

Influence of socioeconomic status on asthma symptoms and atopy: results form the European community respiratory health survey (ECRHS)
Source: Eur Respir J 2002; 20: Suppl. 38, 8s
Year: 2002

The primary care routine data registry BeoNet: First pilot phase results for COPD research
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015

The Spanish national clinical audit on COPD exacerbations. results of a pilot study: spirometry outcomes
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008


The prevalence and impact of autoantibodies among people with bronchiectasis: a data analysis of the EMBARC registry
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021


Sex related differences in aetiology, severity and quality of life in bronchiectasis: data from the EMBARC, EMBARC-India and Australian bronchiectasis registries
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020